BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 20096922)

  • 1. Peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian peritoneal carcinomatosis: an argued role.
    Di Giorgio A; Cardi M; Sammartino P
    Gynecol Oncol; 2010 Apr; 117(1):146-7. PubMed ID: 20096922
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of pegylated liposomal doxorubicin administered by intraoperative hyperthermic intraperitoneal chemotherapy to patients with advanced ovarian cancer and peritoneal carcinomatosis.
    Salvatorelli E; De Tursi M; Menna P; Carella C; Massari R; Colasante A; Iacobelli S; Minotti G
    Drug Metab Dispos; 2012 Dec; 40(12):2365-73. PubMed ID: 22972909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
    Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
    Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer.
    Di Giorgio A; Naticchioni E; Biacchi D; Sibio S; Accarpio F; Rocco M; Tarquini S; Di Seri M; Ciardi A; Montruccoli D; Sammartino P
    Cancer; 2008 Jul; 113(2):315-25. PubMed ID: 18473354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.
    Roviello F; Pinto E; Corso G; Pedrazzani C; Caruso S; Filippeschi M; Petrioli R; Marsili S; Mazzei MA; Marrelli D
    J Surg Oncol; 2010 Nov; 102(6):663-70. PubMed ID: 20721959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
    Cascales Campos PA; Gil Martínez J; Galindo Fernández PJ; Gil Gómez E; Martínez Frutos IM; Parrilla Paricio P
    Eur J Surg Oncol; 2011 Jun; 37(6):543-8. PubMed ID: 21489742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing evidence for change in ovarian cancer surgery--proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis.
    Chua TC; Liauw W; Robertson G; Morris DL
    Gynecol Oncol; 2009 Oct; 115(1):166-168. PubMed ID: 19604568
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
    Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
    In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer.
    Muñoz-Casares FC; Rufián S; Rubio MJ; Díaz CJ; Díaz R; Casado A; Arjona A; Muñoz-Villanueva MC; Muntané J
    Clin Transl Oncol; 2009 Nov; 11(11):753-9. PubMed ID: 19917539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is hyperthermic intraoperative peritoneal chemotherapy and systemic chemotherapy as effective as standard intraperitoneal chemotherapy: time for a prospective trial?
    Edwards RP
    Gynecol Oncol; 2011 Aug; 122(2):207-8. PubMed ID: 21763889
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intraperitoneal chemo-hyperthermia in the treatment of peritoneal carcinomatosis of ovarian origin. Initial cases, physiopathologic data].
    Salle B; Gilly FN; Carry PY; Sayag A; Brachet A; Braillon G
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(4):369-71. PubMed ID: 8360435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis.
    Chua TC; Liauw W; Robertson G; Chia WK; Soo KC; Alobaid A; Al-Mohaimeed K; Morris DL
    Gynecol Oncol; 2009 Jul; 114(1):137-9; author reply 139. PubMed ID: 19368962
    [No Abstract]   [Full Text] [Related]  

  • 14. [Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
    Königsrainer I; Aschoff P; Zieker D; Beckert S; Glatzle J; Pfannenberg C; Miller S; Hartmann JT; Schroeder TH; Brücher BL; Königsrainer A
    Zentralbl Chir; 2008 Sep; 133(5):468-72. PubMed ID: 18924046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of laparoscopic peritonectomy followed by intra-peritoneal chemohyperthermia: an experimental study.
    Ferron G; Gesson-Paute A; Classe JM; Querleu D
    Gynecol Oncol; 2005 Nov; 99(2):358-61. PubMed ID: 16112182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis].
    Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M
    Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multidisciplinary therapy for peritoneal dissemination using peritonectomy].
    Yonemura Y; Kinoshita K; Takahashi S; Bando E; Kawamura S; Maeda A; Nagata S; Uesaka K; Yamaguchi S; Tsubosa Y; Sasaki T; Endo Y; Tanaka M; Sawa T; Matsuki N
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2178-83. PubMed ID: 12484031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma.
    Cascales PA; Gil J; Galindo PJ; Machado F; Frutos IM; Paricio PP
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):361-2. PubMed ID: 21676527
    [No Abstract]   [Full Text] [Related]  

  • 19. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ; Bruin S; Boot H; van Slooten G; van Tinteren H
    Ann Surg Oncol; 2008 Sep; 15(9):2426-32. PubMed ID: 18521686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.